{
  "id": 2384120,
  "title": "As Trump 2.0 targets federal research, a new study shows the stakes",
  "url": "https://urgent.news/2026/08/21/as-trump-2-0-targets-federal-research-a-new-study-shows-the-stakes",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T13:00:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/as-trump-2-0-targets-federal-research-a-new-study-shows-the-stakes/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The biopharma industry tipped the scales on cancer research years ago. Where the federal government once played a major role in determining what was studied in clinical trials, industry players took a commanding lead. And ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}